Daniel Snyder, PhD has worked for over 25 years in the pharmaceutical industry on a wide range of biological products, and especially botulinum toxin, for the last 10 years. Dr. Snyder is Senior Director, Medical Affairs at Revance Therapeutics, Inc. in Newark, California, USA. He has worked in the Medical Affairs departments and supported botulinum toxin product launches at both Allergan and Ipsen. At Revance, Dr. Snyder leads all Medical Affairs activities and his responsibilities include botulinum toxin technical support and scientific communication.